[The influence of cutaneously applied hyaluronidase on thrombin inhibitor and the clearing factor of human plasma].
D000279:Administration, Cutaneous; D000925:Anticoagulants; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000494:pharmacology*; D007857:Leadership; D008049:Lipase; D008071:Lipoprotein Lipase / Q000097:blood*; D008074:Lipoproteins; D013917:Thrombin / Q000037:antagonists & inhibitors*
D000925:Anticoagulants; D008074:Lipoproteins; D008049:Lipase; D008071:Lipoprotein Lipase; D006821:Hyaluronoglucosaminidase; D013917:Thrombin
HYALURONIDASE/pharmacology; LIPOPROTEIN LIPASE/blood; THROMBIN/antagonists